Covista (CVSA) Q3 2026: Walden Enrollment Jumps 12%, Accelerating Platform Leverage
Walden’s double-digit enrollment growth and Chamberlain’s return to positive momentum signal Covista’s platform is gaining operational leverage and competitive separation. Strategic execution across marketing, program expansion, and AI-driven learning underpin both near-term results and long-term positioning. Guidance raise and campus buildout signal confidence in demand durability as the company enters its next phase of scale.
Summary
- Walden’s Enrollment Surge: Record student growth validates Covista’s program expansion and persistence strategy.
- Chamberlain Inflection: Operational fixes are restoring growth, with funnel conversion and marketing gains now visible in results.
- Capital Flexibility Expands: Free cash flow and balance sheet strength enable simultaneous investment and shareholder returns.
Business Overview
Covista operates a national platform for healthcare workforce education, generating revenue through degree programs, clinical partnerships, and credentialing across three core segments: Chamberlain (nursing), Walden (healthcare and behavioral sciences), and Medical & Veterinary. The company’s model connects education supply directly to healthcare system demand, leveraging employer partnerships and technology-driven learning to address persistent talent shortages.
Performance Analysis
Covista delivered broad-based enrollment growth across all three segments, with Walden leading at 12.3% year-over-year, and Chamberlain returning to positive total enrollment growth ahead of plan. The quarter’s financials were impacted by a one-week academic calendar shift at Walden, but on a normalized basis, revenue and EBITDA demonstrated strong double-digit organic growth, underscoring the platform’s operational leverage.
Segment results highlight Walden’s compounding effect—driven by new programs and improved student persistence—while Chamberlain’s turnaround is now visible in both pre-licensure and post-licensure nursing. Medical & Veterinary maintained steady growth, with margin expansion reflecting process improvements and automation. Trailing 12-month free cash flow rose 17% to $336 million, supporting both campus expansion and $66 million in share repurchases. The refinancing of long-term debt, lowering rates and extending maturity, further enhanced capital flexibility.
- Enrollment-Driven Leverage: Underlying EBITDA margin expanded across segments, most notably at Walden, where operational efficiency and scale drove 280 basis points of margin improvement (excluding timing effects).
- Chamberlain’s Positive Turn: Application and conversion rates sharply improved after targeted marketing and process changes, with pre-licensure nursing marking a 15th straight quarter of enrollment growth.
- Investment in Growth: Capital deployment ramped up for campus buildout and digital initiatives, with Q4 CapEx expected to rise further as new locations and AI programs scale.
Overall, the platform’s ability to translate enrollment gains into expanding margins and cash flow is strengthening, positioning Covista to capture outsized share as healthcare labor imbalances persist.
Executive Commentary
"Three things define this quarter. First, we surpassed 100,000 students, achieved our 11th consecutive quarter of total enrollment growth, and delivered record enrollment at both Chamberlain and Walden. Second, Chamberlain returned to positive total enrollment growth ahead of our expectations. The operating changes that we committed to are in fact working. Third, the strength of our results gives us the confidence to raise both revenue and adjusted EPS guidance for the year."
Steve Beard, Chairman and Chief Executive Officer
"We continue to benefit from a robust financial foundation while increasing our level of profitability through scale and operational excellence, all while deploying capital in a balanced and disciplined fashion."
Bob Phelan, Chief Financial Officer
Strategic Positioning
1. Enrollment Engine and Funnel Optimization
Covista’s return to growth at Chamberlain is rooted in localized marketing, streamlined application processes, and talent upgrades in enrollment operations. Application volumes rose double digits, and conversion rates normalized, indicating the remediation efforts are driving sustainable improvement. The company’s disciplined approach to funnel management now sets a higher base for the coming academic cycles.
2. Program Expansion and Speed to Market
Walden’s rapid launch of new programs in clinical psychology, behavioral analysis, palliative care, and special education demonstrates a competitive advantage in curriculum agility. Seven new programs were approved, with three already enrolling, supporting record enrollment and providing a template for future high-demand offerings.
3. AI-Powered Learning and Clinical Integration
Strategic partnership with Google Cloud is advancing both AI-powered classroom pilots and new credential programs—over 4,000 learners have already enrolled in AI-focused certificates. The establishment of the Covista Healthcare Readiness AI Council, featuring leading clinical executives, anchors the technology push in real-world healthcare needs, positioning Covista as a differentiated provider of AI fluency for healthcare professionals.
4. Capital Allocation and Balance Sheet Strength
Free cash flow growth and a sub-1x net leverage ratio provide Covista with latitude to invest in campus expansion, digital initiatives, and opportunistic buybacks. The recent debt refinancing and $66 million in repurchases reflect a commitment to both growth and shareholder value, while maintaining optionality for future M&A or strategic partnerships.
5. Leadership and Execution Discipline
The appointment of new leaders at Chamberlain and in growth/innovation roles signals a focus on operational excellence and market responsiveness. Execution discipline is now a visible differentiator, with leadership emphasizing transparency and accountability in capital and resource allocation.
Key Considerations
This quarter’s results reinforce Covista’s position as a scaled, agile healthcare education platform, but the next phase will test the durability of recent improvements and the scalability of new initiatives.
Key Considerations:
- Enrollment Momentum Sustainability: Chamberlain’s positive turn is a key inflection, but sustaining growth through the critical fall cycle will be decisive for long-term share gains.
- Program Launch Velocity: Walden’s ability to maintain rapid new program rollout in high-demand fields will be a core driver of future growth and margin expansion.
- AI Integration Depth: Early traction in AI credentials is promising, but the real test will be embedding AI into the core learning experience and employer partnerships at scale.
- Capital Deployment Balance: Managing simultaneous campus expansion, technology investment, and shareholder returns will require tight execution and clear ROI discipline.
Risks
Execution risk remains elevated as Covista ramps up campus openings and expands digital offerings, with the potential for cost overruns or slower-than-expected enrollment conversion. Healthcare labor market dynamics could shift if macroeconomic or regulatory factors alter provider hiring patterns. Continued dependence on federal funding for student aid and evolving accreditation standards present ongoing compliance and demand risks, while competitive intensity in online and hybrid healthcare education is rising.
Forward Outlook
For Q4, Covista guided to:
- Continued positive enrollment growth at Chamberlain, with growth rates expected to mirror Q3 levels
- Further ramp in CapEx as campus development accelerates
For full-year 2026, management raised guidance:
- Revenue now expected in the range of $1.93 billion to $1.945 billion, representing 8% to 9% growth
- Adjusted EPS guidance increased to $7.95 to $8.15, reflecting 19% to 22% growth
Management emphasized confidence in demand visibility, a commitment to margin expansion, and ongoing investment in strategic growth initiatives as they enter fiscal 2027.
- Positive signals in application and conversion rates support Q4 enrollment outlook
- Elevated investment in digital and campus expansion factored into guidance
Takeaways
Covista’s Q3 results mark a decisive inflection in operational execution and strategic momentum, with enrollment and margin growth compounding across the platform.
- Platform Leverage on Display: Enrollment gains at Walden and Chamberlain translated directly into margin and cash flow expansion, validating the scale advantages of Covista’s model.
- Execution Reset at Chamberlain: Remediation of enrollment funnel and marketing issues has restored growth, but sustaining this through the next enrollment cycle is critical.
- Watch for Next-Phase AI and Campus Ramp: The ability to scale AI-driven learning and execute on multi-campus buildout will determine whether Covista can extend its lead in healthcare workforce education.
Conclusion
Covista’s third quarter underscores a platform moving from stabilization to renewed growth, powered by disciplined execution, targeted investments, and strong demand tailwinds. The company’s guidance raise and capital flexibility set the stage for durable outperformance, but the coming quarters will test its ability to sustain momentum and scale innovation.
Industry Read-Through
Covista’s results signal that demand for healthcare education remains robust, with digital and hybrid models gaining traction as talent shortages persist across the sector. The company’s ability to launch new programs quickly and embed AI into the curriculum highlights the growing importance of agility and technology in workforce development. For peers in education and healthcare staffing, the bar for operational discipline and capital allocation is rising, while partnerships with employers and tech providers are becoming increasingly central to competitive differentiation. Investors should monitor how other education platforms respond to the accelerating convergence of clinical demand, digital delivery, and AI-enabled learning.